Table of Content
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF THE NORTH AMERICA PINGUECULUM DRUGS MARKET
1.4 CURRENCY AND PRICING
1.5 LIMITATIONS
1.6 MARKETS COVERED
2 NORTH AMERICA PINGUECULUM DRUGS MARKET: SEGMENTATION
2.1 MARKETS COVERED
2.2 GEOGRAPHICAL SCOPE
2.3 YEARS CONSIDERED FOR THE STUDY
2.4 CURRENCY AND PRICING
2.5 DBMR TRIPOD DATA VALIDATION MODEL
2.6 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.7 MULTIVARIATE MODELLING
2.8 TREATMENT LIFELINE CURVE
2.9 DBMR MARKET POSITION GRID
2.1 VENDOR SHARE ANALYSIS
2.11 MARKET END-USER COVERAGE GRID
2.12 SECONDARY SOURCES
2.13 ASSUMPTIONS
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
4.1 EPIDERMIOLOGY
4.2 PESTEL ANALYSIS
4.3 PORTER’S FIVE FORCES
4.4 PIPELINE ANALYSIS FOR THE NORTH AMERICA PINGUECULUM DRUGS MARKET
4.5 INDUSTRIAL INSIGHTS:
4.6 CONCLUSION:
5 NORTH AMERICA PINGUECULUM DRUGS MARKET: REGULATIONS
6 MARKET OVERVIEW
6.1 DRIVERS
6.1.1 RISING PREVALENCE OF PINGUECELA DISORDERS AND OCULAR PAINS
6.1.2 RISE IN THE CHRONIC UV RADIATION EXPOSURE DUE TO OZONE DEFECT
6.1.3 INCREASING AWARENESS AMONG PEOPLE FOR EYE-RELATED DISEASES
6.1.4 RISING OPHTHALMIC EMERGENCIES IN THE GERIATRIC PATIENT
6.2 RESTRAINTS
6.2.1 STRINGENT RULES & REGULATIONS
6.2.2 LACK OF HEALTHCARE FACILITIES FOR EYE TREATMENT
6.3 OPPORTUNITIES
6.3.1 INITIATIVES AND PLANS TO LESSEN THE PREVALENCE OF EYE ILLNESSES
6.3.2 INCREASING RESEARCH AND DEVELOPMENT ACTIVITIES
6.3.3 INCREASE IN HEALTHCARE SPENDING AND ACCESSIBLE INCOME
6.4 CHALLENGES
6.4.1 ADVERSE EFFECTS OF STEROID EYE DROPS
6.4.2 LACK OF SKILLED OPHTHALMOLOGISTS
7 NORTH AMERICA PINGUECULUM DRUGS MARKET, BY TREATMENT
7.1 OVERVIEW
7.2 ARTIFICIAL TEARS/TOPICAL LUBRICANTS
7.2.1 DEMULCENT
7.2.2 EMOLLIENTS
7.3 STEROID EYE DROPS
7.3.1 KETONE STEROIDS
7.3.1.1 PREDNISOLONE
7.3.1.2 DEXAMETHASONE
7.3.1.3 FLUROMETHOLONE
7.3.1.4 MEDRYSONE
7.3.1.5 RIMEXOLONE
7.3.1.6 OTHERS
7.3.2 ESTER STEROID (LOTERPREDNOL)
7.4 NON-STEROIDAL ANTI-INFLAMMATORY DROPS
7.5 OTHERS
8 NORTH AMERICA PINGUECULUM DRUGS MARKET, BY FORMULATION
8.1 OVERVIEW
8.2 EYE DROPS
8.2.1 EYE DROPS WITH PRESERVATIVES
8.2.2 PRESERVATIVE-FREE EYE DROPS
8.3 EYE OINTMENTS
8.3.1 WITH PRESERVATIVES
8.3.2 PRESERVATIVE-FREE
8.3.3 OTHERS
8.4 OTHERS
9 NORTH AMERICA PINGUECULUM DRUGS MARKET, MODE OF PURCHASE
9.1 OVERVIEW
9.2 PRESCRIPTION
9.3 OVER THE COUNTER (OTC)
10 NORTH AMERICA PINGUECULUM DRUGS MARKET, BY DRUGS TYPE
10.1 OVERVIEW
10.2 BRANDED
10.3 GENERICS
11 NORTH AMERICA PINGUECULUM DRUGS MARKET, BY POPULATION TYPE
11.1 OVERVIEW
11.2 GERIATRIC
11.2.1 MALE
11.2.2 FEMALE
11.3 ADULTS
11.3.1 MALE
11.3.2 FEMALE
12 NORTH AMERICA PINGUECULUM DRUGS MARKET, BY END USER
12.1 OVERVIEW
12.2 HOSPITALS
12.3 SPECIALTY CLINICS
12.4 HOME HEALTHCARE
12.5 OTHERS
13 NORTH AMERICA PINGUECULUM DRUGS MARKET, BY DISTRIBUTION CHANNEL
13.1 OVERVIEW
13.2 RETAIL PHARMACIES
13.3 HOSPITAL PHARMACIES
13.4 ONLINE PHARMACIES
13.5 OTHERS
14 NORTH AMERICA PINGUECULUM DRUGS MARKET, BY REGION
14.1 NORTH AMERICA
14.1.1 U.S.
14.1.2 MEXICO
14.1.3 CANADA
15 NORTH AMERICA PINGUECULUM DRUGS MARKET: COMPANY LANDSCAPE
15.1 COMPANY SHARE ANALYSIS: NORTH AMERICA
16 SWOT ANALYSIS
17 COMPANY PROFILE
17.1 ALCON INC.
17.1.1 COMPANY SNAPSHOT
17.1.2 REVENUE ANALYSIS
17.1.3 COMPANY SHARE ANALYSIS
17.1.4 PRODUCT PORTFOLIO
17.1.5 RECENT DEVELOPMENT
17.2 ABBVIE INC.
17.2.1 COMPANY SNAPSHOT
17.2.2 REVENUE ANALYSIS
17.2.3 COMPANY SHARE ANALYSIS
17.2.4 PRODUCT PORTFOLIO
17.2.5 RECENT DEVELOPMENT
17.3 BAUSCH & LOMB INCORPORATED
17.3.1 COMPANY SNAPSHOT
17.3.2 REVENUE ANALYSIS
17.3.3 COMPANY SHARE ANALYSIS
17.3.4 PRODUCT PORTFOLIO
17.3.5 RECENT DEVELOPMENT
17.4 BAYER AG
17.4.1 COMPANY SNAPSHOT
17.4.2 REVENUE ANALYSIS
17.4.3 COMPANY SHARE ANALYSIS
17.4.4 PRODUCT PORTFOLIO
17.4.5 RECENT DEVELOPMENTS
17.5 JOHNSON & JOHNSON VISION CARE, INC.
17.5.1 COMPANY SNAPSHOT
17.5.2 REVENUE ANALYSIS
17.5.3 COMPANY SHARE ANALYSIS
17.5.4 PRODUCT PORTFOLIO
17.5.5 RECENT DEVELOPMENT
17.6 AKORN OPERATING COMPANY LLC
17.6.1 COMPANY SNAPSHOT
17.6.2 . PRODUCT PORTFOLIO
17.6.3 RECENT DEVELOPMENT
17.7 AMNEAL PHARMACEUTICALS LLC.
17.7.1 COMPANY SNAPSHOT
17.7.2 REVENUE ANALYSIS
17.7.3 PRODUCT PORTFOLIO
17.7.4 RECENT DEVELOPMENTS
17.8 EYERIS VISIONCARE PVT. LTD.
17.8.1 COMPANY SNAPSHOT
17.8.2 PRODUCT PORTFOLIO
17.8.3 RECENT DEVELOPMENTS
17.9 LABORATOIRES THÉA
17.9.1 COMPANY SNAPSHOT
17.9.2 PRODUCT PORTFOLIO
17.9.3 RECENT DEVELOPMENT
17.1 MAYA BIOTECH PRIVATE LIMITED
17.10.1 COMPANY SNAPSHOT
17.10.2 PRODUCT PORTFOLIO
17.10.3 RECENT DEVELOPMENTS
17.11 NOVARTIS AG
17.11.1 COMPANY SNAPSHOT
17.11.2 REVENUE ANALYSIS
17.11.3 PRODUCT PORTFOLIO
17.11.4 RECENT DEVELOPMENT
17.12 OASIS MEDICAL, INC.
17.12.1 COMPANY SNAPSHOT
17.12.2 PRODUCT PORTFOLIO
17.12.3 RECENT DEVELOPMENT
17.13 PRESTIGE CONSUMER HEALTHCARE, INC.
17.13.1 COMPANY SNAPSHOT
17.13.2 PRODUCT PORTFOLIO
17.13.3 RECENT DEVELOPMENT
17.14 SAGER PHARMA
17.14.1 COMPANY SNAPSHOT
17.14.2 PRODUCT PORTFOLIO
17.14.3 RECENT DEVELOPMENTS
17.15 SANTEN PHARMACEUTICAL CO., LTD.
17.15.1 COMPANY SNAPSHOT
17.15.2 REVENUE ANALYSIS
17.15.3 PRODUCT PORTFOLIO
17.15.4 RECENT DEVELOPMENTS
17.16 SIMILASAN CORPORATION
17.16.1 COMPANY SNAPSHOT
17.16.2 PRODUCT PORTFOLIO
17.16.3 RECENT DEVELOPMENTS
17.17 SPECTRA VISION CARE
17.17.1 COMPANY SNAPSHOT
17.17.2 PRODUCT PORTFOLIO
17.17.3 RECENT DEVELOPMENTS
17.18 SYLENTIS
17.18.1 COMPANY SNAPSHOT
17.18.2 PRODUCT PORTFOLIO
17.18.3 RECENT DEVELOPMENTS
17.19 WELLONA PHARMA
17.19.1 COMPANY SNAPSHOT
17.19.2 PRODUCT PORTFOLIO
17.19.3 RECENT DEVELOPMENTS
17.2 ZYDUS GROUP
17.20.1 COMPANY SNAPSHOT
17.20.2 REVENUE ANALYSIS
17.20.3 PRODUCT PORTFOLIO
17.20.4 RECENT DEVELOPMENTS
18 QUESTIONNAIRE
19 RELATED REPORTS
List of Table
TABLE 1 NORTH AMERICA PINGUECULUM DRUGS MARKET, BY TREATMENT, 2020-2029 (USD MILLION)
TABLE 2 NORTH AMERICA ARTIFICIAL TEARS/TOPICAL LUBRICANTS IN PINGUECULUM DRUGS MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 3 NORTH AMERICA ARTIFICIAL TEARS/TOPICAL LUBRICANTS IN PINGUECULUM DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 4 NORTH AMERICA STEROID EYE DROPS IN PINGUECULUM DRUGS MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 5 NORTH AMERICA STEROID EYE DROPS IN PINGUECULUM DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 6 NORTH AMERICA KETONE STEROIDS IN PINGUECULUM DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 7 NORTH AMERICA NON-STEROIDAL ANTI-INFLAMMATORY DROPS IN PINGUECULUM DRUGS MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 8 NORTH AMERICA OTHERS IN PINGUECULUM DRUGS MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 9 NORTH AMERICA PINGUECULUM DRUGS MARKET, BY FORMULATION, 2020-2029 (USD MILLION)
TABLE 10 NORTH AMERICA EYE DROPS IN PINGUECULUM DRUGS MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 11 NORTH AMERICA EYE DROPS IN PINGUECULUM DRUGS MARKET, BY FORMULATION, 2020-2029 (USD MILLION)
TABLE 12 NORTH AMERICA EYE OINTMENTS IN PINGUECULUM DRUGS MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 13 NORTH AMERICA EYE OINTMENTS IN PINGUECULUM DRUGS MARKET, BY FORMULATION, 2020-2029 (USD MILLION)
TABLE 14 NORTH AMERICA OTHERS IN PINGUECULUM DRUGS MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 15 NORTH AMERICA PINGUECULUM DRUGS MARKET, BY MODE OF PURCHASE, 2020-2029 (USD MILLION)
TABLE 16 NORTH AMERICA PRESCRIPTION IN PINGUECULUM DRUGS MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 17 NORTH AMERICA OVER THE COUNTER (OTC) IN PINGUECULUM DRUGS MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 18 NORTH AMERICA PINGUECULUM DRUGS MARKET, BY DRUGS TYPE, 2020-2029 (USD MILLION)
TABLE 19 NORTH AMERICA BRANDED IN PINGUECULUM DRUGS MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 20 NORTH AMERICA GENERICS IN PINGUECULUM DRUGS MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 21 NORTH AMERICA PINGUECULUM DRUGS MARKET, BY POPULATION TYPE, 2020-2029 (USD MILLION)
TABLE 22 NORTH AMERICA GERIATRIC IN PINGUECULUM DRUGS MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 23 NORTH AMERICA GERIATRIC IN PINGUECULUM DRUGS MARKET, BY POPULATION TYPE, 2020-2029 (USD MILLION)
TABLE 24 NORTH AMERICA ADULTS IN PINGUECULUM DRUGS MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 25 NORTH AMERICA ADULTS IN PINGUECULUM DRUGS MARKET, BY POPULATION TYPE, 2020-2029 (USD MILLION)
TABLE 26 NORTH AMERICA PINGUECULUM DRUGS MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 27 NORTH AMERICA HOSPITALS IN PINGUECULUM DRUGS MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 28 NORTH AMERICA SPECIALTY CLINICS IN PINGUECULUM DRUGS MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 29 NORTH AMERICA HOME HEALTHCARE IN PINGUECULUM DRUGS MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 30 NORTH AMERICA OTHERS IN PINGUECULUM DRUGS MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 31 NORTH AMERICA PINGUECULUM DRUGS MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)
TABLE 32 NORTH AMERICA RETAIL PHARMACIES IN PINGUECULUM DRUGS MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 33 NORTH AMERICA HOSPITAL PHARMACIES IN PINGUECULUM DRUGS MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 34 NORTH AMERICA ONLINE PHARMACIES IN PINGUECULUM DRUGS MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 35 NORTH AMERICA OTHERS IN PINGUECULUM DRUGS MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 36 NORTH AMERICA PINGUECULUM DRUGS MARKET, BY COUNTRY, 2020-2029 (USD MILLION)
TABLE 37 NORTH AMERICA PINGUECULUM DRUGS MARKET, BY TREATMENT, 2020-2029 (USD MILLION)
TABLE 38 NORTH AMERICA ARTIFICIAL TEARS/TOPICAL LUBRICANTS IN PINGUECULUM DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 39 NORTH AMERICA STEROID EYE DROPS IN PINGUECULUM DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 40 NORTH AMERICA KETONE STEROIDS IN PINGUECULUM DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 41 NORTH AMERICA PINGUECULUM DRUGS MARKET, BY FORMULATION, 2020-2029 (USD MILLION)
TABLE 42 NORTH AMERICA EYE DROPS IN PINGUECULUM DRUGS MARKET, BY FORMULATION, 2020-2029 (USD MILLION)
TABLE 43 NORTH AMERICA EYE OINTMENTS IN PINGUECULUM DRUGS MARKET, BY FORMULATION, 2020-2029 (USD MILLION)
TABLE 44 NORTH AMERICA PINGUECULUM DRUGS MARKET, BY MODE OF PURCHASE, 2020-2029 (USD MILLION)
TABLE 45 NORTH AMERICA PINGUECULUM DRUGS MARKET, BY DRUGS TYPE, 2020-2029 (USD MILLION)
TABLE 46 NORTH AMERICA PINGUECULUM DRUGS MARKET, BY POPULATION TYPE, 2020-2029 (USD MILLION)
TABLE 47 NORTH AMERICA GERIATRIC IN PINGUECULUM DRUGS MARKET, BY POPULATION TYPE, 2020-2029 (USD MILLION)
TABLE 48 NORTH AMERICA ADULTS IN PINGUECULUM DRUGS MARKET, BY POPULATION TYPE, 2020-2029 (USD MILLION)
TABLE 49 NORTH AMERICA PINGUECULUM DRUGS MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 50 NORTH AMERICA PINGUECULUM DRUGS MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)
TABLE 51 U.S. PINGUECULUM DRUGS MARKET, BY TREATMENT, 2020-2029 (USD MILLION)
TABLE 52 U.S. ARTIFICIAL TEARS/TOPICAL LUBRICANTS IN PINGUECULUM DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 53 U.S. STEROID EYE DROPS IN PINGUECULUM DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 54 U.S. KETONE STEROIDS IN PINGUECULUM DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 55 U.S. PINGUECULUM DRUGS MARKET, BY FORMULATION, 2020-2029 (USD MILLION)
TABLE 56 U.S. EYE DROPS IN PINGUECULUM DRUGS MARKET, BY FORMULATION, 2020-2029 (USD MILLION)
TABLE 57 U.S. EYE OINTMENTS IN PINGUECULUM DRUGS MARKET, BY FORMULATION, 2020-2029 (USD MILLION)
TABLE 58 U.S. PINGUECULUM DRUGS MARKET, BY MODE OF PURCHASE, 2020-2029 (USD MILLION)
TABLE 59 U.S. PINGUECULUM DRUGS MARKET, BY DRUGS TYPE, 2020-2029 (USD MILLION)
TABLE 60 U.S. PINGUECULUM DRUGS MARKET, BY POPULATION TYPE, 2020-2029 (USD MILLION)
TABLE 61 U.S. GERIATRIC IN PINGUECULUM DRUGS MARKET, BY POPULATION TYPE, 2020-2029 (USD MILLION)
TABLE 62 U.S. ADULTS IN PINGUECULUM DRUGS MARKET, BY POPULATION TYPE, 2020-2029 (USD MILLION)
TABLE 63 U.S. PINGUECULUM DRUGS MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 64 U.S. PINGUECULUM DRUGS MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)
TABLE 65 MEXICO PINGUECULUM DRUGS MARKET, BY TREATMENT, 2020-2029 (USD MILLION)
TABLE 66 MEXICO ARTIFICIAL TEARS/TOPICAL LUBRICANTS IN PINGUECULUM DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 67 MEXICO STEROID EYE DROPS IN PINGUECULUM DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 68 MEXICO KETONE STEROIDS IN PINGUECULUM DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 69 MEXICO PINGUECULUM DRUGS MARKET, BY FORMULATION, 2020-2029 (USD MILLION)
TABLE 70 MEXICO EYE DROPS IN PINGUECULUM DRUGS MARKET, BY FORMULATION, 2020-2029 (USD MILLION)
TABLE 71 MEXICO EYE OINTMENTS IN PINGUECULUM DRUGS MARKET, BY FORMULATION, 2020-2029 (USD MILLION)
TABLE 72 MEXICO PINGUECULUM DRUGS MARKET, BY MODE OF PURCHASE, 2020-2029 (USD MILLION)
TABLE 73 MEXICO PINGUECULUM DRUGS MARKET, BY DRUGS TYPE, 2020-2029 (USD MILLION)
TABLE 74 MEXICO PINGUECULUM DRUGS MARKET, BY POPULATION TYPE, 2020-2029 (USD MILLION)
TABLE 75 MEXICO GERIATRIC IN PINGUECULUM DRUGS MARKET, BY POPULATION TYPE, 2020-2029 (USD MILLION)
TABLE 76 MEXICO ADULTS IN PINGUECULUM DRUGS MARKET, BY POPULATION TYPE, 2020-2029 (USD MILLION)
TABLE 77 MEXICO PINGUECULUM DRUGS MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 78 MEXICO PINGUECULUM DRUGS MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)
TABLE 79 CANADA PINGUECULUM DRUGS MARKET, BY TREATMENT, 2020-2029 (USD MILLION)
TABLE 80 CANADA ARTIFICIAL TEARS/TOPICAL LUBRICANTS IN PINGUECULUM DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 81 CANADA STEROID EYE DROPS IN PINGUECULUM DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 82 CANADA KETONE STEROIDS IN PINGUECULUM DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 83 CANADA PINGUECULUM DRUGS MARKET, BY FORMULATION, 2020-2029 (USD MILLION)
TABLE 84 CANADA EYE DROPS IN PINGUECULUM DRUGS MARKET, BY FORMULATION, 2020-2029 (USD MILLION)
TABLE 85 CANADA EYE OINTMENTS IN PINGUECULUM DRUGS MARKET, BY FORMULATION, 2020-2029 (USD MILLION)
TABLE 86 CANADA PINGUECULUM DRUGS MARKET, BY MODE OF PURCHASE, 2020-2029 (USD MILLION)
TABLE 87 CANADA PINGUECULUM DRUGS MARKET, BY DRUGS TYPE, 2020-2029 (USD MILLION)
TABLE 88 CANADA PINGUECULUM DRUGS MARKET, BY POPULATION TYPE, 2020-2029 (USD MILLION)
TABLE 89 CANADA GERIATRIC IN PINGUECULUM DRUGS MARKET, BY POPULATION TYPE, 2020-2029 (USD MILLION)
TABLE 90 CANADA ADULTS IN PINGUECULUM DRUGS MARKET, BY POPULATION TYPE, 2020-2029 (USD MILLION)
TABLE 91 CANADA PINGUECULUM DRUGS MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 92 CANADA PINGUECULUM DRUGS MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)
List of Figure
FIGURE 1 NORTH AMERICA PINGUECULUM DRUGS MARKET: SEGMENTATION
FIGURE 2 NORTH AMERICA PINGUECULUM DRUGS MARKET: DATA TRIANGULATION
FIGURE 3 NORTH AMERICA PINGUECULUM DRUGS MARKET: DROC ANALYSIS
FIGURE 4 NORTH AMERICA PINGUECULUM DRUGS MARKET: NORTH AMERICA VS REGIONAL MARKET ANALYSIS
FIGURE 5 NORTH AMERICA PINGUECULUM DRUGS MARKET: COMPANY RESEARCH ANALYSIS
FIGURE 6 NORTH AMERICA PINGUECULUM DRUGS MARKET: INTERVIEW DEMOGRAPHICS
FIGURE 7 NORTH AMERICA PINGUECULUM DRUGS MARKET: DBMR POSITION GRID
FIGURE 8 NORTH AMERICA PINGUECULUM DRUGS MARKET: VENDOR SHARE ANALYSIS
FIGURE 9 NORTH AMERICA PINGUECULUM DRUGS MARKET: END USER COVERAGE GRID
FIGURE 10 NORTH AMERICA PINGUECULUM DRUGS MARKET: SEGMENTATION
FIGURE 11 INCREASING PREVALENCE OF OPHTHALMIC DISORDERS AND THE RISE IN THE GERIATRIC POPULATION ARE EXPECTED TO DRIVE THE NORTH AMERICA PINGUECULUM DRUGS MARKET GROWTH FROM 2022 TO 2029
FIGURE 12 ARTIFICIAL TEARS/TOPICAL LUBRICANTS SEGMENT IS EXPECTED TO HAVE THE LARGEST SHARE OF THE NORTH AMERICA PINGUECULUM DRUGS MARKET FROM 2022 & 2029
FIGURE 13 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF THE NORTH AMERICA PINGUECULUM DRUGS MARKET
FIGURE 14 NORTH AMERICA PINGUECULUM DRUGS MARKET: BY TREATMENT, 2021
FIGURE 15 NORTH AMERICA PINGUECULUM DRUGS MARKET: BY TREATMENT, 2022-2029 (USD MILLION)
FIGURE 16 NORTH AMERICA PINGUECULUM DRUGS MARKET: BY TREATMENT, CAGR (2022-2029)
FIGURE 17 NORTH AMERICA PINGUECULUM DRUGS MARKET: BY TREATMENT, LIFELINE CURVE
FIGURE 18 NORTH AMERICA PINGUECULUM DRUGS MARKET: BY FORMULATION, 2021
FIGURE 19 NORTH AMERICA PINGUECULUM DRUGS MARKET: BY FORMULATION, 2022-2029 (USD MILLION)
FIGURE 20 NORTH AMERICA PINGUECULUM DRUGS MARKET: BY FORMULATION, CAGR (2022-2029)
FIGURE 21 NORTH AMERICA PINGUECULUM DRUGS MARKET: BY FORMULATION, LIFELINE CURVE
FIGURE 22 NORTH AMERICA PINGUECULUM DRUGS MARKET: BY MODE OF PURCHASE, 2021
FIGURE 23 NORTH AMERICA PINGUECULUM DRUGS MARKET: BY MODE OF PURCHASE, 2022-2029 (USD MILLION)
FIGURE 24 NORTH AMERICA PINGUECULUM DRUGS MARKET: BY MODE OF PURCHASE, CAGR (2022-2029)
FIGURE 25 NORTH AMERICA PINGUECULUM DRUGS MARKET: BY MODE OF PURCHASE, LIFELINE CURVE
FIGURE 26 NORTH AMERICA PINGUECULUM DRUGS MARKET: BY DRUGS TYPE, 2021
FIGURE 27 NORTH AMERICA PINGUECULUM DRUGS MARKET: BY DRUGS TYPE, 2022-2029 (USD MILLION)
FIGURE 28 NORTH AMERICA PINGUECULUM DRUGS MARKET: BY DRUGS TYPE, CAGR (2022-2029)
FIGURE 29 NORTH AMERICA PINGUECULUM DRUGS MARKET: BY DRUGS TYPE, LIFELINE CURVE
FIGURE 30 NORTH AMERICA PINGUECULUM DRUGS MARKET: BY POPULATION TYPE, 2021
FIGURE 31 NORTH AMERICA PINGUECULUM DRUGS MARKET: BY POPULATION TYPE, 2022-2029 (USD MILLION)
FIGURE 32 NORTH AMERICA PINGUECULUM DRUGS MARKET: BY POPULATION TYPE, CAGR (2022-2029)
FIGURE 33 NORTH AMERICA PINGUECULUM DRUGS MARKET: BY POPULATION TYPE, LIFELINE CURVE
FIGURE 34 NORTH AMERICA PINGUECULUM DRUGS MARKET: BY END USER, 2021
FIGURE 35 NORTH AMERICA PINGUECULUM DRUGS MARKET: BY END USER, 2022-2029 (USD MILLION)
FIGURE 36 NORTH AMERICA PINGUECULUM DRUGS MARKET: BY END USER, CAGR (2022-2029)
FIGURE 37 NORTH AMERICA PINGUECULUM DRUGS MARKET: BY END USER, LIFELINE CURVE
FIGURE 38 NORTH AMERICA PINGUECULUM DRUGS MARKET: BY DISTRIBUTION CHANNEL, 2021
FIGURE 39 NORTH AMERICA PINGUECULUM DRUGS MARKET: BY DISTRIBUTION CHANNEL, 2022-2029 (USD MILLION)
FIGURE 40 NORTH AMERICA PINGUECULUM DRUGS MARKET: BY DISTRIBUTION CHANNEL, CAGR (2022-2029)
FIGURE 41 NORTH AMERICA PINGUECULUM DRUGS MARKET: BY DISTRIBUTION CHANNEL, LIFELINE CURVE
FIGURE 42 NORTH AMERICA PINGUECULUM DRUGS MARKET: SNAPSHOT (2021)
FIGURE 43 NORTH AMERICA PINGUECULUM DRUGS MARKET: BY COUNTRY (2021)
FIGURE 44 NORTH AMERICA PINGUECULUM DRUGS MARKET: BY COUNTRY (2022 & 2029)
FIGURE 45 NORTH AMERICA PINGUECULUM DRUGS MARKET: BY COUNTRY (2021 & 2029)
FIGURE 46 NORTH AMERICA PINGUECULUM DRUGS MARKET: BY TREATMENT (2022-2029)
FIGURE 47 NORTH AMERICA PINGUECULUM DRUGS MARKET: COMPANY SHARE 2021 (%)
